Prospective observational study of epidemiological surveillance, multicenter, non-profit, spontaneous, Italian with objective to describe the incidence of CMV infections and diseases in adult and pediatric patients undergoing allo-HSCT during the first 6 months from transplant. This study will evaluate approximately 1500 subjects (with competitive enrolment) from GITMO investigational centers.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cytomegalovirus infection
Timeframe: 6 months from transplant
Cytomegalovirus disease
Timeframe: 6 months from transplant
Herpesvirus human 6 infection
Timeframe: 6 months from transplant
Herpesvirus human 6 disease
Timeframe: 6 months from transplant
Virus Epstein-Barr infection
Timeframe: 6 months from transplant
Virus Epstein-Barr disease
Timeframe: 6 months from transplant